We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

A Landmark Study Demonstrates that ‘Complexes Matter’ in How Epigenetic Inhibitors Interact with Their Drug Targets

News   Jan 24, 2011

 
A Landmark Study Demonstrates that ‘Complexes Matter’ in How Epigenetic Inhibitors Interact with Their Drug Targets
 
 
 

RELATED ARTICLES

Tracking Down Missing-in-Action Multiple Sclerosis Genes

News

Previous work by the International Multiple Sclerosis Genetics Consortium (IMSGC) has identified 233 genetic risk variants. However, these only account for about 20% of overall disease risk, with the remaining genetic culprits proving elusive. A new study has tracked down four of these hard-to-find genes.

READ MORE

Study Identifies Effective Ketamine Doses for Treatment-Resistant Depression

News

Study identifies two subanesthetic dosage levels of the anesthetic drug ketamine that appear to provide significant symptom relief to patients with treatment-resistant depression.

READ MORE

Fruit Fly Protein Could Help Tackle Disease-Carrying Mosquitos

News

An insulin-binding protein in fruit flies could provide new opportunities for tackling mosquitoes that carry diseases such as malaria and yellow fever, scientists at the University of York have found.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE